Trial intelligence / Profile preview

Buphenyl and Low-Dose Arginine vs High-Dose Arginine in ASA

NCT00345605Phase 2Completed

Start
Feb 2008
Primary completion
May 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium phenylbutyrate in argininosuccinic aciduria (ASA). Started Feb 2008; status: completed.

02

Drugs

sodium phenylbutyrate
03

Conditions

argininosuccinic aciduria (ASA)

Beyond the preview

Go deeper on NCT00345605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00345605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call